NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
Back to search
Official data from USPTO
MONSPHERE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/07/2025
Trademark type
Combined
Nice classes
5, 10
Filing date
02/10/2022
Registration date
11/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/28/2023
Last transaction
02/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
TR
Examiner
SPILS, CAROL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI
Representatives
Michael F. Swartz Egbert, McDaniel & Swartz, PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals preparations for the treatment and prevention of cancer; Medical preparations for the treatment of cancer and cancerous tumors; Veterinary preparations for cancer and cancerous tumors for animals; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer for medical and veterinary purposes; Ginseng capsules for medical purposes; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for the diagnosis of pregnancy for medical and pharmaceutical purposes; chemical preparations for sanitary purposes for veterinary purposes; chemicopharmaceutical preparations for the treatment of cancer; Drug delivery agents in the form of beadspillsliquidcapsulesdissolvable filmscoatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of a coating for drug and pharmaceuticals preparations that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of circulatory diseases; pharmaceutical preparations for embolization for the treatment of blood vessels; pharmaceutical preparations for embolization of tumours and arteriovenous malformations (AVMs) for the treatment of circulatory conditions; pharmaceutical preparations for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medical purposesvaccine adjuvants and adjuvants for use with vaccines; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations for the treatment of the circulatory systemvaccines and Antitoxic sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; diagnostic preparations for medical purposes; radioactive substances for medical purposesradioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposesradioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticalsradiopharmaceuticals for the treatment of cancer; radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; pharmaceutical preparations in the form of particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microcapsules containing pharmaceuticalveterinary or medical preparations for the treatment of cancer; pharmaceutical preparations in the form of microcapsules and microparticles adapted to selectively deliver radioactivity to a target for the treatment of cancer; pharmaceutical preparations in the form of microscopic particles and microcapsules for the treatment of cancer and other diseased cells; pharmaceutical preparations in the form of microscopic particles adapted to selectively deliver radioactive material to a target site such as a cell or organ for the treatment of cancer
Class 10
Surgical and medical apparatus and instruments for the treatment of cancerradiological apparatus for medical purposesradiology screens for medical purposesradiation shields for protection against X-rays for medical purposes; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body for the treatment of cancer; drug delivery embolisation apparatusinstruments and systems; medical apparatus and instruments for embolisation for the treatment of cancer; beadsimpregnated with radioactive material or radioactive pharmaceutical preparations; microscopic glass beads being medical devices impregnated with radioactive material or radioactive pharmaceutical preparations and administered surgically for treatment of cancerous tumors; glass beads being medical devices containing radioactive material for the treatment of cancerous tumors; glass beads being medical devices containing radioactive pharmaceutical preparations for the treatment of cancerous tumors; implantable radiation therapy devices consisting of radioactive beadsbeads in the nature of microscopic radioactive beads for treatment of cancerous tumours; radioactive glass beadsimplantable radiation therapy devices consisting of radioactive beads for treatment of cancerous tumours; radioactive beadsimplantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical deviceapparatus and instruments for treating cancer; Surgical and medical apparatus and instrumentscathetersinjection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatusinstruments and systems comprising surgical and medical instruments for embolisationembolic devices for use in treating cancer and tumorsembolic devices for treating arteriovenous malformations (AVMs) of the bodyembolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instrumentsa drug delivery system comprised of injection syringessealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolisationembolisation apparatusinstruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisationembolisation apparatusinstruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation for the treatment of cancer; surgical and medical apparatus and instruments for use in the circulatory system for the treatment of cancer; needles for medical usecannula needles; medical devices for performing cryotherapycryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues for the treatment of cancer; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment for the treatment of cancer; surgical and medical devicesapparatus and instruments for use in cryoablationthe treatment of prostate cancerkidney or renal tumoursbenign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles for treating cancer; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treating cancer; medical devices for ablating human and animal tissue using microwave energy for treating cancer; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts thereforfor all the aforesaid goods; medical apparatus and instrumentsbeads impregnated with radioactive material for treatment of cancerous tumorsbeads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumoursbeads containing radioactive materialglass beads containing radioactive pharmaceutical preparationsmicroscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumorsbeads in the nature of microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumours
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/08/2024
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/02/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
03/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2023
PUBO
PUBLISHED FOR OPPOSITION
09/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/30/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2023
RFNT
REFUSAL PROCESSED BY IB
03/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/08/2023
RFRR
REFUSAL PROCESSED BY MPU
03/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/12/2023
CNRT
NON-FINAL ACTION WRITTEN
01/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2022
DOCK
ASSIGNED TO EXAMINER
12/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/23/2022
Continuous trademark protection
Get notified about every new filing that threatens MONSPHERE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.